financetom
Business
financetom
/
Business
/
Bandhan Bank Q2 profit down 5% at Rs 920 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bandhan Bank Q2 profit down 5% at Rs 920 cr
Nov 2, 2020 6:16 AM

Bandhan Bank on Monday reported 5.3 percent decline in net profit at Rs 920 crore for September quarter of the current fiscal year. The bank clocked a net profit of Rs 971.80 crore in the same period of 2019-20.

Total income grew 22 percent to Rs 2,304.90 crore in July-September 2020-21 as against Rs 1,889.30 crore in the year-ago period, Bandhan Bank said in a regulatory filing. Net interest income of the Kolkata-headquartered lender jumped 25.8 percent to Rs 1,923.1 crore during the quarter while the non-interest income grew 6.1 percent to Rs 381.8 crore.

Bandhan Bank said it has reported the highest ever quarterly profit before tax at Rs 1,233 crore during the period under review. Net Interest Margin (annualised) in the quarter fell to 8 percent against 8.2 percent in year-ago period. During the quarter, the bank took accelerated additional provision on standard advances amounting to Rs 300 crore. With this provision and the additional standard assets provision that bank is carrying in micro banking portfolio, the total additional provision in books stands at Rs 2,096 crore, it said.

The bank’s gross non-performing assets fell to 1.2 percent (Rs 874 crore) of gross advances as of September 30, 2020 as against 1.8 percent (Rs 1,064.20 crore) by the year-ago same period. Net NPAs too improved to 0.4 percent (Rs 262.50 crore) from 0.6 percent (Rs 336.90 crore).

”As the moratorium ended on 31st August 2020 coupled with robust rural performance, we have seen an all-round improvement in collection, disbursement and deposits. On deposits front, we have witnessed the best ever quarter whereas on the disbursement front, we are close to pre-COVID-19 level.”

Collections have seen a steady improvement month-on-month and is expected to reach near normal in the next 90 days. We now look forward to accelerate the business in H2FY 21,” Managing Director and CEO Chandra Shekhar Ghosh said. Total Advances grew 19.4 percent to Rs 76,614.6 crore as on September 30, 2020. Total deposits increased 34.4 percent to Rs 66,127.7 crore.

Bandhan Bank stock was trading at Rs 305.50 on BSE, up 5.62 percent from the previous close.

First Published:Nov 2, 2020 3:16 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fate Therapeutics Reports Positive Preclinical Data for Cancer Treatment Candidate
Fate Therapeutics Reports Positive Preclinical Data for Cancer Treatment Candidate
Nov 9, 2024
04:53 PM EST, 11/08/2024 (MT Newswires) -- Fate Therapeutics ( FATE ) said late Friday that preclinical data for its CAR T-cell candidate FT836 demonstrated the product's potential for durable anti-tumor activity without intervention. The data support the pan-cancer activity of MICA/B targeting, and indicate that our next-generation, iPSC-derived CAR T-cell platform has the potential to drive potent and durable...
Enphase Energy to lay off 17% of workforce
Enphase Energy to lay off 17% of workforce
Nov 9, 2024
(Reuters) -Enphase Energy will cut its global workforce by about 17%, impacting about 500 employees and contractors, the solar inverter maker disclosed in a filing on Friday. Enphase will also streamline its operations by focusing contract manufacturing in four existing locations - two in the United States, one in India and one in China. The company will cease its contract...
Beam Therapeutics Insider Sold Shares Worth $1,347,050, According to a Recent SEC Filing
Beam Therapeutics Insider Sold Shares Worth $1,347,050, According to a Recent SEC Filing
Nov 9, 2024
04:23 PM EST, 11/08/2024 (MT Newswires) -- Giuseppe Ciaramella, President, on November 06, 2024, sold 51,110 shares in Beam Therapeutics ( BEAM ) for $1,347,050. Following the Form 4 filing with the SEC, Ciaramella has control over a total of 109,150 shares of the company, with 109,150 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1745999/000095017024124085/xslF345X05/ownership.xml ...
Moog Insider Sold Shares Worth $298,979, According to a Recent SEC Filing
Moog Insider Sold Shares Worth $298,979, According to a Recent SEC Filing
Nov 9, 2024
04:01 PM EST, 11/08/2024 (MT Newswires) -- Brian J Lipke, Director, on November 07, 2024, sold 1,343 shares in Moog ( MOG/A ) (MOGA, MOGB) for $298,979. Following the Form 4 filing with the SEC, Lipke has control over a total of 19,765 shares of the company, with 19,765 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/67887/000006788724000085/xslF345X05/wk-form4_1731099060.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved